The objective of Finnish healthcare technology company Lymphatouch’s negative pressure treatment is to improve patients’ quality of life by reducing pain and tissue swelling. Innokas Medical is...
Recent Posts
FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, has now reached a significant milestone as the device has received CE mark and the sales has started....
Innokas Medical has entered into manufacturing collaboration with Swedish medical technology company ScandiDos AB. This collaboration brings yet another Swedish customer to Innokas, providing...
New Product Introduction (NPI) and Design Transfer are both important parts of the whole life cycle of medical product from idea to market launch. Successful prototype series and professional...
Swedish health tech innovator Coala Life AB selected Innokas Medical to manufacture Coala Heart Monitor, which has global market potential.
Innokas Medical continues internationalization; the company has entered into an agreement with Swedish medtech company Alcosystems AB. The agreement brought yet another Swedish customer to...
The cooperation between Innokas Medical and Monidor Ltd. has developed to the next level during this year. The first steps of the cooperation were took already in 2015 when Innokas was offering QA...
Innokas Medical and the Norwegian company Luzmon Medical AS have recently signed a manufacturing contract for the Luzmon’s cTEMS and cTENS system including some NPI and sourcing work. The...
Sensapex Oy and Innokas Medical, both of whose headquarters are located in Oulu area, have been satisfied with the two-way customer-supplier relationship. The local cooperation saves time and...
To improve the production practices Innokas has invest in new technologies as well as re-organized its production layout at Kempele factory during the last 12 months. The newest invest was the new...
